Emergence of blaNDM-1 and blaVIM producing Gram-negative bacilli in ventilator-associated pneumonia at AMR

Mithlesh Kumari1, Sheetal Verma1, Vimala Venkatesh1

  • 1Department of Microbiology, King George's Medical University, Lucknow, Uttar Pradesh, India.

Plos One
|September 8, 2021
PubMed
Abstract

Insights

Ventilator-associated pneumonia (VAP) is a serious infection, with carbapenem-resistant Gram-negative pathogens posing a global threat. Early detection of carbapenemase genes like blaNDM and blaVIM in VAP patients is crucial for controlling their spread.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Critical Care Medicine

Background:

  • Ventilator-associated pneumonia (VAP) is a life-threatening nosocomial infection common in intensive care units.
  • The increasing prevalence of carbapenem-resistant Gram-negative pathogens presents a significant global health challenge.

Purpose of the Study:

  • To investigate the prevalence of carbapenem resistance in Gram-negative pathogens causing VAP.
  • To identify specific carbapenemase genes, such as blaNDM and blaVIM, in VAP isolates.
  • To assess the clinical associations and outcomes of VAP in the context of antimicrobial resistance.

Main Methods:

  • Endotracheal aspirates from mechanically ventilated patients (>48h) were analyzed.
  • Bacterial isolates were identified using MALDI-TOF-MS and antibiotic susceptibility testing.
  • Carbapenem-resistant isolates underwent Modified Hodge Test (MHT), mCIM, eCIM, and PCR for MBL genes (blaIMP, blaVIM, blaNDM).

Main Results:

  • VAP occurred in 48.7% of patients, with late-onset VAP being more prevalent (76.7%).
  • 58.6% of Gram-negative isolates were carbapenem-resistant, with Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae being common pathogens.
  • PCR detected blaNDM in 21.5% and blaVIM in 17.4% of isolates; 8.7% carried both genes.

Conclusions:

  • blaNDM-1 and blaVIM genes are key drivers of carbapenem resistance in VAP, indicating the public health concern of carbapenem-resistant Enterobacteriaceae (CRE).
  • Early detection of Metallo-beta-lactamase (MBL) genes in diagnostic laboratories is essential to limit the dissemination of these resistance genes.

Related Concept Videos

Rapid Identification of Pathogens01:25

Rapid Identification of Pathogens

MALDI-TOF MS has transformed clinical microbiology by offering a rapid and reliable method for pathogen identification. The traditional approach to microbial identification typically involves time-consuming culture techniques and biochemical tests, which can delay the initiation of appropriate antimicrobial therapy. MALDI-TOF MS avoids these delays by using characteristic ribosomal protein mass patterns of microbial cells, enabling accurate species-level identification within minutes.Principle...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...